What's breaking now, across thousands of outlets.
(MedPage Today) -- We heard about the outbreak by accident. In December 2025, I (Meyer) was chatting with a friend who has a teenager in a rival San Francisco high school. Our conversation turned to football first, then to prom. "It's going great...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
uniQure has aligned with the FDA on what the company calls key elements of the confirmatory study design: The study is being designed as a randomized, standard-of-care trial enrolling approximately…
The US Food and Drug Administration on Monday approved a low-cost version of a twice-yearly HIV prevention shot, bringing the breakthrough drug closer to market in low-income countries.
Two studies involving investigators at Cedars-Sinai Guerin Children's and the University of Cambridge, U.K., highlight the growing potential of whole-genome sequencing to transform the diagnosis and…
Ewing sarcoma is a rare and debilitating type of bone cancer affecting young adults and children. Despite intensive treatment with chemotherapy, surgery and radiation, many children do not overcome…
The US Food and Drug Administration on Monday approved a low-cost version of a twice-yearly HIV prevention shot, bringing the breakthrough drug closer to market in low-income countries.
After seeing people in his life face cancer diagnoses, the “Saved by the Bell” star is speaking out about the importance of biomarker testing and sharing how his approach to managing his own health…
